Skip to main content

David B. Colleran

Equibles does not estimate personal net worth.

Get an email with a short summary when Anika Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ANIK alerts

About David B. Colleran

David B. Colleran is recorded as General Counsel at Anika Therapeutics, Inc. (ANIK). The newest filing on record that lists David B. Colleran as General Counsel at Anika Therapeutics, Inc. (ANIK) is dated April 28, 2026. The proxy statement of Anika Therapeutics, Inc. reports total compensation of $1,668,587 for David B. Colleran in fiscal 2024, including a base salary of $481,996. Disclosed compensation is on record for 7 fiscal years. Anika Therapeutics, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Anika Therapeutics, Inc. includes Cheryl Blanchard (CEO and Board Member), Stephen (Steve) Griffin (CEO and Board Member), Stephen D. Griffin (CEO, CFO and Board Member) and 7 others.

Affiliation history

Company network

Leadership on record at Anika Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Anika Therapeutics, Inc. (ANIK) $481,996 $1,668,587
2023 Anika Therapeutics, Inc. (ANIK) $469,900 $1,550,514
2022 Anika Therapeutics, Inc. (ANIK) $449,700 $1,651,635
2021 Anika Therapeutics, Inc. (ANIK) $432,400 $1,400,513
2020 Anika Therapeutics, Inc. (ANIK) $344,077 $1,705,616
2019 Anika Therapeutics, Inc. (ANIK) — —
2018 Anika Therapeutics, Inc. (ANIK) — —

Recent activity

No call appearances or filed executive changes recorded yet.